Search

Your search keyword '"Grille-Cancela, Z."' showing total 45 results

Search Constraints

Start Over You searched for: Author "Grille-Cancela, Z." Remove constraint Author: "Grille-Cancela, Z."
45 results on '"Grille-Cancela, Z."'

Search Results

1. Elevated lipoprotein a level in heart transplant patients is associated with cardiac allograft vasculopathy

2. Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry

3. Sex‐ and age‐related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long‐Term Registry

4. Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry

5. Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry

6. Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry

7. Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world

8. Perioperative Pectoralis Muscle Mass and Attenuation Estimated by Computed Tomography are Not Predictors for Mortality after Heart Transplantation

9. Improvement of Adherence to Drug Therapy Using a Weekly Multidose Pillbox in Heart Transplant Patients. A Prospective Single-Center Study

10. Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry

11. Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry

12. Unravelling the interplay between hyperkalaemia, renin–angiotensin–aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry

13. Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry

14. P5455Serum microRNA-181a-5p expression pattern correlates with acute cellular rejection in heart transplantation

15. Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry

17. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry

20. Venous Thromboembolism in Heart Transplant Patients: Incidence, Clinical Characteristics and Risk Factors

22. Are There Differences in the Development of Proteinuria after Everolimus Initiation and Calcineurin Withdrawal or Not in Heart Transplantation?

23. Cumulative Incidence of Cytomegalovirus Infection and Disease After Heart Transplantation in the Last Decade: Effect of Preemptive Therapy

25. 662 Incidence of Rejection after Conversion to Proliferation Signal Inhibitors after Heart Transplantation. Is There any Difference between CNI-Free vs CNI Minimization Regimens?

26. 487 Oral Sildenafil: A Safe and Effective Treatment of Persistent Pulmonary Hypertension after Heart Transplantation

28. 496 Risk Factors for Nosocomial Infection in the Post-Operative Period after Heart Transplantation

29. Conversion of Heart Transplant Patients From Standard to Sustained-Release Tacrolimus Requires a Dosage Increase

30. Efficacy and Tolerance of Different Types of Prophylaxis for Prevention of Early Aspergillosis After Heart Transplantation

34. Reduced mitochondrial pyruvate carrier expression in hearts with heart failure and reduced ejection fraction patients: ischemic vs. non-ischemic origin.

35. Soluble HLA-G levels in heart transplant recipients: Dynamics and correlation with clinical outcomes.

36. Cancer in patients with heart failure: Incidence, risk factors and prognostic impact.

37. Determinants of maximal oxygen uptake in patients with heart failure.

38. Comparison of predicted and observed mortality in patients with heart failure treated at a specialized unit.

39. Incidence, risk factors and prognostic impact of cytomegalovirus infection after heart transplantation.

40. Circulating Galectin-3 Following Heart Transplant: Long-term Dynamics and Prognostic Value.

41. Polymorphisms in genes related to the complement system and antibody-mediated cardiac allograft rejection.

42. Analysis of variants in the HCN4 gene and in three single nucleotide polymorphisms of the CYP3A4 gene for association with ivabradine reduction in heart rate: A preliminary report.

43. Prognostic Significance of Heart Rate and its Long-term Trend in Cardiac Transplant Patients.

44. Clinical evaluation of rosuvastatin in heart transplant patients with hypercholesterolemia and therapeutic failure of other statin regimens: short-term and long-term efficacy and safety results.

45. Venous thromboembolism in heart transplant recipients: incidence, recurrence and predisposing factors.

Catalog

Books, media, physical & digital resources